99% Savings - Buy Just @1 Rs X
Olsavas M 20/25 Tablet is a prescription medicine that is available as a Tablet. The alternative uses of Olsavas M 20/25 Tablet have also been explained below.
The optimal dosage of Olsavas M 20/25 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Olsavas M 20/25 Tablet are Upper respiratory tract infection, Slow heart rate (pulse). While these are the most often observed Olsavas M 20/25 Tablet side effects, there are can be others also. These have been listed below. Such side effects of Olsavas M 20/25 Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
In addition, Olsavas M 20/25 Tablet's effect is Severe during pregnancy and Mild for lactating mothers. It is important to know if Olsavas M 20/25 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Olsavas M 20/25 Tablet related warnings section.
Olsavas M 20/25 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Bradycardia (Slow Heart Rate) are examples of such conditions. The section on Olsavas M 20/25 Tablet contraindications lists all such conditions.
Additionally, Olsavas M 20/25 Tablet may also adversely react with other medicines. A complete list of these interactions is given below.
You should also be aware that Olsavas M 20/25 Tablet is not safe while driving, and is not addiction.
Olsavas M 20/25 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Olsavas M 20/25 Tablet safe for pregnant women?
Olsavas M can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Olsavas M 20/25 Tablet safe during breastfeeding?
Side effects of Olsavas M on breastfeeding women are very mild.
What is the effect of Olsavas M 20/25 Tablet on the Kidneys?
Using Olsavas M does not have any harmful effects on kidneys.
What is the effect of Olsavas M 20/25 Tablet on the Liver?
Olsavas M is rarely harmful for the liver.
What is the effect of Olsavas M 20/25 Tablet on the Heart?
Olsavas M has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Olsavas M 20/25 Tablet unless your doctor advises you to do so -
Is this Olsavas M 20/25 Tablet habit forming or addictive?
Olsavas M 20/25 Tablet does not cause addiction.
Interaction between Food and Olsavas M 20/25 Tablet
Some foods when eaten with Olsavas M 20/25 Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Olsavas M 20/25 Tablet
Consumption of alcohol and Olsavas M 20/25 Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850